FDA Inspection 1277727 — Sarepta Therapeutics Inc
The FDA completed an inspection of Sarepta Therapeutics Inc on July 15, 2025 in Andover, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Andover, MA (United States)